GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.
Clinical trial NCT00381303 · COMPLETED
Trial details
- NCT number
- NCT00381303
- Sponsor
- Tibotec, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2008-11-01
- Enrollment
- 429
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.